Molecular Aspects of the FAH Mutations Involved in HT1 Disease

作者: Geneviève Morrow , Francesca Angileri , Robert M. Tanguay

DOI: 10.1007/978-3-319-55780-9_3

关键词:

摘要: Abstract Hereditary tyrosinemia type 1 (HT1) is caused by the lack of fumarylacetoacetate hydrolase (FAH), the last enzyme of the tyrosine catabolic pathway. Up to now, around 100 mutations in the FAH gene have been associated with HT1, and despite many efforts, no clear correlation between genotype and clinical phenotype has been reported. At first, it seems that any mutation in the gene results in HT1. However, placing these mutations in their molecular context allows a better understanding of their possible effects. This chapter …

参考文章(72)
Li-Min Dou, Ling-Juan Fang, Xiao-Hong Wang, Wei Lu, Rui Chen, Li-Ting Li, Jing Zhao, Jian-She Wang, None, Mutation analysis of FAH gene in patients with tyrosinemia type 1 Chinese journal of pediatrics. ,vol. 51, pp. 302- 307 ,(2013) , 10.3760/CMA.J.ISSN.0578-1310.2013.04.013
S. K. Heath, R. G. F. Gray, P. McKiernan, K. M. Au, E. Walker, A. Green, Mutation screening for tyrosinaemia type I Journal of Inherited Metabolic Disease. ,vol. 25, pp. 523- 524 ,(2002) , 10.1023/A:1021275923668
László Tiszlavicz, Eszter Karg, Agnes Janovszky, Aranka László, Gyula Wittmann, Agnes Várkonyi, Eva Sallay, Mária Rózsa, Magdalena Ugarte, Sándor Túri, The fate of tyrosinaemic Hungarian patients before the NTBC aera. Ideggyogyaszati Szemle-clinical Neuroscience. ,vol. 66, pp. 415- 419 ,(2013)
H. Rootwelt, E. Brodtkorb, E. A. Kvittingen, Identification of a frequent pseudodeficiency mutation in the fumarylacetoacetase gene, with implications for diagnosis of tyrosinemia type I. American Journal of Human Genetics. ,vol. 55, pp. 1122- 1127 ,(1994)
Tomás Honzík, Dagmar Procházkova, Jirí Zeman, Martin Magner, Markéta Tesarová, Alzbeta Vondrácková, Petr Chrastina, Dagmar Docekalová, [Clinical, biochemical and molecular characteristics in 11 Czech children with tyrosinemia type I]. Casopís lékar̆ů c̆eských. ,vol. 149, pp. 411- 416 ,(2010)
Arden K, Tanguay Rm, Cavenee W, Labelle Y, Bérubé D, Gagné R, Phaneuf D, Cloning and expression of the cDNA encoding human fumarylacetoacetate hydrolase, the enzyme deficient in hereditary tyrosinemia: assignment of the gene to chromosome 15. American Journal of Human Genetics. ,vol. 48, pp. 525- 535 ,(1991)
S. Z. Kim, K. G. Kupke, L. Ierardi-Curto, E. Holme, J. Greter, R. M. Tanguay, J. Poudrier, M. D'Astous, F. Lettre, S. H. Hahn, H. L. Levy, Hepatocellular carcinoma despite long-term survival in chronic tyrosinaemia I Journal of Inherited Metabolic Disease. ,vol. 23, pp. 791- 804 ,(2000) , 10.1023/A:1026756501669
A. Dursun, R. K. Özgül, S. Sivri, A. Tokatlı, A. Güzel, L. Mesci, M. Kılıç, D. Aliefendioglu, F. Özçay, M. Gündüz, T. Coşkun, Mutation Spectrum of Fumarylacetoacetase Gene and Clinical Aspects of Tyrosinemia Type I Disease JIMD Reports. ,vol. 1, pp. 17- 21 ,(2011) , 10.1007/8904_2011_10
Kvittingen Ea, Berger R, Gray G, Kelly Da, Rootwelt H, Coşkun T, Novel splice, missense, and nonsense mutations in the fumarylacetoacetase gene causing tyrosinemia type 1. American Journal of Human Genetics. ,vol. 55, pp. 653- 658 ,(1994)
Giancarlo la Marca, Sabrina Malvagia, Elisabetta Pasquini, Catia Cavicchi, Amelia Morrone, Federica Ciani, Silvia Funghini, Fabio Villanelli, Enrico Zammarchi, Renzo Guerrini, Newborn Screening for Tyrosinemia Type I: Further Evidence that Succinylacetone Determination on Blood Spot Is Essential Journal of Inherited Metabolic Disease. ,vol. 1, pp. 107- 109 ,(2011) , 10.1007/8904_2011_24